Some Seniors Are Seeing Prescription Coverage Gaps Widen

For over a decade, the “donut hole” was the most feared phrase in senior healthcare, representing a mid-year jump in drug costs that forced many to choose between medicine and groceries. In 2026, that specific coverage gap is officially a thing of the past, but many retirees are finding that new prescription coverage gaps have emerged in its place. While federal reforms have introduced a landmark $2,100 out-of-pocket cap, the “path” to reaching that cap has become steeper and more expensive for those on fixed incomes. Between rising annual deductibles and a shift from flat copays to percentage-based coinsurance, the way you pay for your life-saving medications has fundamentally changed this year.

The End of the Donut Hole, The Rise of the Cap

The most significant change to prescription coverage gaps this year is the full implementation of the $2,100 annual out-of-pocket maximum. Under the provisions of the Inflation Reduction Act, once you spend $2,100 on covered Part D drugs (including your deductible), you enter “Catastrophic Coverage” and pay $0 for the rest of the year. This is a massive win for those with high-cost conditions like cancer or rheumatoid arthritis. However, for the millions of seniors who typically spend $1,000 to $1,800 a year, this cap provides no relief. Instead, they are facing a “front-loaded” cost structure that can feel like a new kind of financial gap in the early months of the year.

The $615 Deductible Hurdle

One of the primary reasons seniors feel the sting of prescription coverage gaps is the record-high standard deductible. The maximum deductible for Part D plans has climbed to $615 this year, up from $590 in 2025. For many, this means your first trip to the pharmacy in January involves paying the full retail price of your medications until that $615 threshold is met. If you are taking a brand-name drug that costs $400 a month, you will be paying 100% of that cost for nearly two months. This “front-end gap” is becoming a significant hurdle for those who didn’t set aside extra savings during the holiday season.

Copays vs. Coinsurance: The New Math

A subtle but expensive shift in plan design is contributing to wider prescription coverage gaps for many. To offset the costs of the new $2,100 cap, many insurance carriers have moved from flat “copays” (e.g., $40 for a Tier 3 drug) to “coinsurance” (e.g., 25% of the drug’s total cost). If your medication has a list price of $800, a 25% coinsurance means you pay $200—a massive jump from a $40 copay. This shift makes monthly costs much more volatile and can cause a senior’s budget to “gap” unexpectedly if the drug’s market price fluctuates.

The “Negotiated Price” Delay Trap

2026 marks the historic debut of Medicare-negotiated prices for 10 major drugs, including Eliquis, Jardiance, and Januvia. While these prices are lower, they have created a unique side effect: because the total cost of the drug is lower, it takes longer for a senior to reach the $2,100 out-of-pocket cap. If you rely on reaching that cap to get “free” drugs for the second half of the year, the lower negotiated prices might actually keep you in the “Initial Coverage” phase longer, where you are still responsible for your 25% share. This “slow-motion” progression toward the cap is an unintended consequence that is catching many budget-conscious seniors by surprise.

Spreading the Cost: The Payment Plan Option

To help bridge these prescription coverage gaps, every Part D plan is now required to offer the Medicare Prescription Payment Plan. This optional program allows you to opt in and spread your out-of-pocket costs over the entire year in monthly installments rather than paying the full amount at the pharmacy counter. While it doesn’t save you money overall, it eliminates the “sticker shock” of the January deductible and high early-year coinsurance. For a senior who knows they will eventually hit the $2,100 cap, this plan turns a few massive “gap” months into 12 manageable, interest-free payments.

Strategies for Closing the Gap

Managing prescription coverage gaps in 2026 requires more than just picking a plan; it requires active management of your “formulary.” If your drug has moved to a coinsurance model, ask your doctor if there is a Tier 1 or Tier 2 generic alternative that still uses a flat copay. Additionally, if you have a limited income, check your eligibility for the Social Security “Extra Help” program, which can eliminate deductibles and cap copays at just a few dollars. By understanding the new rules of the road, you can ensure that the end of the donut hole actually leads to the financial security it was intended to provide.

Have you noticed your pharmacy bills jumping this month despite the new $2,100 cap? Leave a comment below and let us know which medications are causing the biggest budget “gaps” for you.